1. Home
  2. GENK vs IRIX Comparison

GENK vs IRIX Comparison

Compare GENK & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEN Restaurant Group Inc.

GENK

GEN Restaurant Group Inc.

N/A

Current Price

$1.66

Market Cap

12.8M

ML Signal

N/A

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

N/A

Current Price

$0.87

Market Cap

15.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GENK
IRIX
Founded
2011
1989
Country
United States
United States
Employees
2700
N/A
Industry
Restaurants
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
15.0M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
GENK
IRIX
Price
$1.66
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.1K
★ 688.2K
Earning Date
11-06-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.50
51.85
EPS
N/A
★ N/A
Revenue
★ $208,380,000.00
$41,593,000.00
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.89
$6.58
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 15.12
N/A
52 Week Low
$1.43
$0.61
52 Week High
$3.20
$1.65

Technical Indicators

Market Signals
Indicator
GENK
IRIX
Relative Strength Index (RSI) 45.36 70.52
Support Level $1.50 $0.80
Resistance Level $1.73 $1.16
Average True Range (ATR) 0.10 0.07
MACD 0.00 0.04
Stochastic Oscillator 33.83 62.32

Price Performance

Historical Comparison
GENK
IRIX

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: